Barrett's Esophagus: Pathogenesis, Treatment, and Prevention

Rami J. Badreddine; Kenneth K. Wang

doi:10.1016/j.giec.2008.05.005

Barrett's Esophagus: Pathogenesis, Treatment, and Prevention

Rami J. Badreddine, Kenneth K. Wang

Gastroenterology and Hepatology

Research output: Contribution to journal › Review article › peer-review

5 Scopus citations

Abstract

Esophageal adenocarcinoma is the most common type of esophageal cancer seen in the United States and Western Europe. Barrett's esophagus (BE) is a well-known risk factor for esophageal adenocarcinoma and is believed to be found in 6% to 12% of patients undergoing endoscopy for gastroesophageal reflux disease and in more than 1% of all patients undergoing endoscopy. This article focuses on the pathogenesis, treatment, and prevention of BE.

Original language	English (US)
Pages (from-to)	495-512
Number of pages	18
Journal	Gastrointestinal Endoscopy Clinics of North America
Volume	18
Issue number	3
DOIs	https://doi.org/10.1016/j.giec.2008.05.005
State	Published - Jul 2008

ASJC Scopus subject areas

Gastroenterology

Access to Document

10.1016/j.giec.2008.05.005

Cite this

@article{2d5adb6007344ea2a2f790061e93d7bd,

title = "Barrett's Esophagus: Pathogenesis, Treatment, and Prevention",

abstract = "Esophageal adenocarcinoma is the most common type of esophageal cancer seen in the United States and Western Europe. Barrett's esophagus (BE) is a well-known risk factor for esophageal adenocarcinoma and is believed to be found in 6% to 12% of patients undergoing endoscopy for gastroesophageal reflux disease and in more than 1% of all patients undergoing endoscopy. This article focuses on the pathogenesis, treatment, and prevention of BE.",

author = "Badreddine, {Rami J.} and Wang, {Kenneth K.}",

note = "Funding Information: Supported by NIH Grants R01 CA111603-01A1, R01CA097048, and R21CA122426-01. ",

year = "2008",

month = jul,

doi = "10.1016/j.giec.2008.05.005",

language = "English (US)",

volume = "18",

pages = "495--512",

journal = "Gastrointestinal Endoscopy Clinics of North America",

issn = "1052-5157",

publisher = "W.B. Saunders Ltd",

number = "3",

}

TY - JOUR

T1 - Barrett's Esophagus

T2 - Pathogenesis, Treatment, and Prevention

AU - Badreddine, Rami J.

AU - Wang, Kenneth K.

N1 - Funding Information: Supported by NIH Grants R01 CA111603-01A1, R01CA097048, and R21CA122426-01.

PY - 2008/7

Y1 - 2008/7

N2 - Esophageal adenocarcinoma is the most common type of esophageal cancer seen in the United States and Western Europe. Barrett's esophagus (BE) is a well-known risk factor for esophageal adenocarcinoma and is believed to be found in 6% to 12% of patients undergoing endoscopy for gastroesophageal reflux disease and in more than 1% of all patients undergoing endoscopy. This article focuses on the pathogenesis, treatment, and prevention of BE.

AB - Esophageal adenocarcinoma is the most common type of esophageal cancer seen in the United States and Western Europe. Barrett's esophagus (BE) is a well-known risk factor for esophageal adenocarcinoma and is believed to be found in 6% to 12% of patients undergoing endoscopy for gastroesophageal reflux disease and in more than 1% of all patients undergoing endoscopy. This article focuses on the pathogenesis, treatment, and prevention of BE.

UR - http://www.scopus.com/inward/record.url?scp=47949125715&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=47949125715&partnerID=8YFLogxK

U2 - 10.1016/j.giec.2008.05.005

DO - 10.1016/j.giec.2008.05.005

M3 - Review article

C2 - 18674699

AN - SCOPUS:47949125715

SN - 1052-5157

VL - 18

SP - 495

EP - 512

JO - Gastrointestinal Endoscopy Clinics of North America

JF - Gastrointestinal Endoscopy Clinics of North America

IS - 3

ER -

Barrett's Esophagus: Pathogenesis, Treatment, and Prevention

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this